| 0 (0%) | 11-11 15:53 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 23.96 |
1-year : | 27.37 |
| Resists | First : | 20.52 |
Second : | 23.44 |
| Pivot price | 21.29 |
|||
| Supports | First : | 15.8 |
Second : | 13.14 |
| MAs | MA(5) : | 19.38 |
MA(20) : | 21.2 |
| MA(100) : | 21.86 |
MA(250) : | 22.45 |
|
| MACD | MACD : | -0.8 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 10.5 |
D(3) : | 24.5 |
| RSI | RSI(14): 18.7 |
|||
| 52-week | High : | 30.11 | Low : | 15.8 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ SGRY ] has closed below the lower bollinger band by 13.2%. Although price has broken the lower band and a downside breakout is possible; the most likely direction for [ SGRY ] is to continue within current trading range. It is unclear right now based on current values. 237.9% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 1 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 18.49 - 18.62 | 18.62 - 18.72 |
| Low: | 15.65 - 15.81 | 15.81 - 15.92 |
| Close: | 15.82 - 16.03 | 16.03 - 16.19 |
Tue, 11 Nov 2025
SGRY's Rating Maintained by RBC Capital Despite Price Target Red - GuruFocus
Tue, 11 Nov 2025
Can Surgery Partners' (SGRY) Updated Guidance Change the Conversation on Profitability? - simplywall.st
Tue, 11 Nov 2025
Surgery Partners (SGRY): Analyst Benchmark Lowers Price Target, Maintains Buy Rating | SGRY Stock News - GuruFocus
Tue, 11 Nov 2025
SGRY Q3 Deep Dive: Guidance Cut Highlights Volume and M&A Timing Pressures - Yahoo Finance
Mon, 10 Nov 2025
Notable Monday Option Activity: TTWO, HEI, SGRY - Nasdaq
Mon, 10 Nov 2025
$SGRY stock is down 25% today. Here's what we see in our data. - Quiver Quantitative
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 128 (M) |
| Shares Float | 69 (M) |
| Held by Insiders | 1.4 (%) |
| Held by Institutions | 113.9 (%) |
| Shares Short | 14,180 (K) |
| Shares Short P.Month | 13,220 (K) |
| EPS | -1.43 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 13.72 |
| Profit Margin | -5.6 % |
| Operating Margin | 14.6 % |
| Return on Assets (ttm) | 3.9 % |
| Return on Equity (ttm) | 0.1 % |
| Qtrly Rev. Growth | 8.3 % |
| Gross Profit (p.s.) | 5.99 |
| Sales Per Share | 25.27 |
| EBITDA (p.s.) | 5.03 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 264 (M) |
| Levered Free Cash Flow | 162 (M) |
| PE Ratio | -11.07 |
| PEG Ratio | 0 |
| Price to Book value | 1.15 |
| Price to Sales | 0.62 |
| Price to Cash Flow | 7.68 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|